State Of Wisconsin Investment Board Neurocrine Biosciences Inc Transaction History

State Of Wisconsin Investment Board

  • $36.9 Billion
  • Q4 2024

A detailed history of State Of Wisconsin Investment Board transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 86,149 shares of NBIX stock, worth $9.96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
86,149
Previous 89,764 4.03%
Holding current value
$9.96 Million
Previous $10.3 Million 13.79%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$111.62 - $139.44 $403,506 - $504,075
-3,615 Reduced 4.03%
86,149 $11.8 Million
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $1.67 Million - $2.23 Million
14,556 Added 19.35%
89,764 $10.3 Million
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $384,597 - $420,835
2,939 Added 4.07%
75,208 $10.4 Million
Q1 2024

May 14, 2024
BUY
$130.4 - $143.74 $2.08 Million - $2.3 Million
15,971 Added 28.37%
72,269 $9.97 Million
Q4 2023

Feb 12, 2024
SELL
$106.07 - $132.76 $55,050 - $68,902
-519 Reduced 0.91%
56,298 $7.42 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $419,611 - $522,617
-4,463 Reduced 7.28%
56,817 $6.39 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $15,578 - $18,247
-174 Reduced 0.28%
61,280 $5.78 Million
Q1 2023

May 15, 2023
SELL
$94.11 - $123.02 $257,955 - $337,197
-2,741 Reduced 4.27%
61,454 $6.22 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $637,972 - $759,564
-5,978 Reduced 8.52%
64,195 $7.67 Million
Q3 2022

Nov 14, 2022
SELL
$92.03 - $107.81 $1.13 Million - $1.33 Million
-12,297 Reduced 14.91%
70,173 $7.45 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $439,657 - $580,506
-5,801 Reduced 6.57%
82,470 $8.04 Million
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $12 Million - $15.7 Million
-166,073 Reduced 65.29%
88,271 $8.28 Million
Q4 2021

Feb 11, 2022
BUY
$79.65 - $106.22 $4.34 Million - $5.79 Million
54,546 Added 27.3%
254,344 $21.7 Million
Q3 2021

Nov 12, 2021
BUY
$86.18 - $99.03 $7.5 Million - $8.61 Million
86,976 Added 77.09%
199,798 $19.2 Million
Q2 2021

Aug 12, 2021
BUY
$89.43 - $102.27 $5.49 Million - $6.28 Million
61,370 Added 119.28%
112,822 $11 Million
Q1 2021

May 17, 2021
SELL
$87.57 - $119.4 $1.07 Million - $1.46 Million
-12,241 Reduced 19.22%
51,452 $5 Million
Q4 2020

Feb 03, 2021
SELL
$86.91 - $108.33 $357,200 - $445,236
-4,110 Reduced 6.06%
63,693 $6.11 Million
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $41,348 - $58,114
430 Added 0.64%
67,803 $6.52 Million
Q2 2020

Aug 12, 2020
SELL
$85.09 - $130.36 $28,930 - $44,322
-340 Reduced 0.5%
67,373 $8.22 Million
Q1 2020

May 06, 2020
SELL
$75.11 - $113.76 $2.79 Million - $4.22 Million
-37,125 Reduced 35.41%
67,713 $5.86 Million
Q4 2019

Feb 14, 2020
BUY
$86.8 - $118.57 $7.99 Million - $10.9 Million
92,035 Added 718.85%
104,838 $11.3 Million
Q3 2019

Nov 12, 2019
SELL
$83.82 - $101.5 $6,202 - $7,511
-74 Reduced 0.57%
12,803 $1.15 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $287,876 - $363,710
-3,985 Reduced 23.63%
12,877 $1.09 Million
Q1 2019

May 13, 2019
SELL
$69.31 - $91.53 $16,634 - $21,967
-240 Reduced 1.4%
16,862 $1.49 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $36,585 - $46,564
-370 Reduced 2.12%
17,102 $2.1 Million
Q2 2018

Aug 03, 2018
SELL
$75.3 - $105.99 $22,062 - $31,055
-293 Reduced 1.65%
17,472 $1.72 Million
Q1 2018

May 07, 2018
SELL
$75.88 - $92.43 $12,596 - $15,343
-166 Reduced 0.93%
17,765 $1.47 Million
Q4 2017

Feb 08, 2018
BUY
$58.53 - $77.59 $8,603 - $11,405
147 Added 0.83%
17,931 $1.39 Million
Q3 2017

Nov 01, 2017
BUY
$47.97 - $61.28 $853,098 - $1.09 Million
17,784
17,784 $1.09 Million

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
95.2M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email